Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Oct 10;157(2):743–753.e3. doi: 10.1016/j.jtcvs.2018.09.098

Table 3.

Chemotherapy Tolerance Between the Neoadjuvant and Adjuvant Groups

Category Neoadjuvant
(N=92; 50%)
Adjuvant
(N=92; 50%)
P
Full dose of chemotherapy 72 (78) 58 (63) 0.014
Full cycles of chemotherapy 84 (91) 72 (78) 0.005
Grade ≥3 adverse reaction to chemotherapy 14 (15) 35 (38) 0.001